Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer
A phase 3 clinical trial co-led by Mount Sinai researchers is the first to show that immunotherapy after surgery to remove bladder cancer can reduce the risk of relapse for patients who are at high risk of their cancer returning ...
Jun 2, 2021
0
2